Overview

Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Status:
Recruiting

Trial end date:
2025-09-01

Target enrollment:

Participant gender:

Summary

The objective of the study is to compare short-term (8 weeks) anticoagulation therapy (DOAC) vs. antiplatelet therapy for the prevention of device thrombosis following transcatheter LAAC.

Phase:

Phase 4

Details

Lead Sponsor:

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

Treatments:

Apixaban
Aspirin
Clopidogrel
Dabigatran
Edoxaban
Rivaroxaban